JPMorgan Healthcare Lead ETFJDOCETF
13F holders, Q1 2025 (March 31)2holders −1
1new positions
2sold out
$53.31avg. 13F price*
At the end of Q1 2025, 2 institutions reported holding JPMorgan Healthcare Lead ETF (JDOC) in their 13F filings, down 1 from Q4 2024. 1 opened new positions and 2 sold out. The largest holders were JPMorgan Chase & Co. ($4.7M) and Royal Bank of Canada ($6K).
- Company
- JPMorgan Healthcare Lead ETF
- CUSIP
- 46654Q765
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $6K |
| Exits | 2 | $1.7M |
All 13F filers, Q4 2024 → Q1 2025: 120 shares bought and 32,814 shares sold, net −32,694 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| JPMorgan Chase & Co. | 0.00% | No change | 88,196 | $4.7M |
| Royal Bank of Canada | 0.00% | New | 120 | $6K |
"% of holder's portfolio" is JDOC's weight in each manager's 13F, not the share of JPMorgan Healthcare Lead ETF the manager owns.